MarginsXMarginsX
Home › Markets › Health Care › IRMD

iRadimed Corporation (IRMD)

IRMD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$84.84
-0.60% on the day
Market cap
$1.1B
Small cap
Revenue · 2025
$83.8M
+14.4% on 2024
Net income · 2025
$22.5M
26.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/0001104659-26-024691-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerIRMD on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2014
SEC CIK0001325618
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$83.8M
Net income$22.5M
Operating income$26.1M
Net margin26.8%
Operating margin31.2%
Revenue growth+14.4%
Cash$51.2M
Total assets$108.8M
P/E (computed)48.3×
P/S (computed)12.9×

Warning signs

Cash runway
Cash-flow positive
$63.3M cash at September 30, 2026
Share count, 1 year
+0.5%
2025-10-31 to 2026-10-30 · +1.4% over 3 years
Going-concern doubt
No
10-Q filed October 30, 2026
Insider net buying, 12 months
-$20.7M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-30
Cash and burn$63.3M cash; operating cash flow $6.8M a quarter.Report 2026-09-30
Shares outstanding12,788,153 (2026-10-30); 12,721,156 a year earlier; 12,605,577 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorRSM US LLP, Orlando, Florida, United StatesPCAOB Form AP 2026-03-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $20.7M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$24.2M$6.5M$7.0M$63.3MNo debt tags$89.3M10-Q 2026-10-30
Q2 2026
2026-06-30
$20.5M$5.2M$5.9M$59.1MNo debt tags$86.3M10-Q 2026-07-31
Q1 2026
2026-03-31
$22.0M$5.8M$8.3M$56.4MNo debt tags$86.3M10-Q 2026-05-01
Q4 2025
2025-12-31
$22.7M$6.4M$5.9M$51.2MNo debt tags$83.8M10-K 2026-03-06
Q3 2025
2025-09-30
$21.2M$5.6M$7.0M$56.5MNo debt tags$80.5M10-Q 2026-10-30
Q2 2025
2025-06-30
$20.4M$5.8M$7.7M$53.0MNo debt tags$77.6M10-Q 2026-07-31
Q1 2025
2025-03-31
$19.5M$4.7M$4.3M$50.3MNo debt tags$75.2M10-Q 2026-05-01
Q4 2024
2024-12-31
$19.4M$5.1M$6.0M$52.2MNo debt tags$73.2M10-K 2026-03-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3
S-32024-04-03
Latest annual report10-K2026-03-06
Latest quarterly / interim10-Q2026-10-30
Latest current report8-K2026-10-30
Latest proxyDEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 777 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.1%
1 month-4.8%
3 months-2.1%
Year to date-12.3%
1 year+1.0%
From 52-week high-18.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B
SIBNSI-BONE Inc.$23.41-0.13%$1.1B
ATECAlphatec Holdings Inc.$6.78-4.10%$1.1B
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B
AORTArtivion Inc.$18.47-3.30%$901.1M
NVCRNovoCure Limited$11.30-4.48%$1.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier